Android app on Google Play

Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps

December 6, 2012 7:29 AM EST Send to a Friend
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.

You May Also Be Interested In

Related Categories

FDA, Trading Halts

Add Your Comment